• Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG).
Auteur:Pavlidis, N; Aamdal, S; Awada, Ahmad; Calvert, H; Fumoleau, Pierre; Sorio, R; Punt, Cornelis; Verweij, Jaap; van Oosterom, A; Morant, Rudolf; Wanders, Jantien; Hanauske, Axel-R
Informations sur la publication:Cancer chemotherapy and pharmacology, 46, 2, page (167-171)
Statut de publication:Publié, 2000
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- therapeutic use
Benzofurans -- administration & dosage
Benzofurans -- adverse effects
Benzofurans -- therapeutic use
Breast Neoplasms -- drug therapy
Colorectal Neoplasms -- drug therapy
Head and Neck Neoplasms -- drug therapy
Indoles -- administration & dosage
Indoles -- adverse effects
Indoles -- therapeutic use
Infusions, Intravenous
Lymphoma, Non-Hodgkin -- drug therapy
Melanoma -- drug therapy
Middle Aged
Neoplasm Staging
Neoplasms -- drug therapy
Neoplasms -- pathology
Ovarian Neoplasms -- drug therapy
Prodrugs -- adverse effects
Prodrugs -- therapeutic use
Stomach Neoplasms -- drug therapy
Note générale:Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study